CO-DIAGNOSTICS INC (CODX) Fundamental Analysis & Valuation

NASDAQ:CODX • US1897632048

Current stock price

1.69 USD
-0.02 (-1.17%)
Last:

This CODX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CODX Profitability Analysis

1.1 Basic Checks

  • CODX had negative earnings in the past year.
  • In the past year CODX has reported a negative cash flow from operations.
  • CODX had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: CODX reported negative operating cash flow in multiple years.
CODX Yearly Net Income VS EBIT VS OCF VS FCFCODX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

1.2 Ratios

  • CODX has a worse Return On Assets (-189.54%) than 90.37% of its industry peers.
  • CODX has a Return On Equity of -227.33%. This is in the lower half of the industry: CODX underperforms 78.61% of its industry peers.
Industry RankSector Rank
ROA -189.54%
ROE -227.33%
ROIC N/A
ROA(3y)-95.27%
ROA(5y)-54.89%
ROE(3y)-112.76%
ROE(5y)-64.69%
ROIC(3y)N/A
ROIC(5y)N/A
CODX Yearly ROA, ROE, ROICCODX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400 600

1.3 Margins

  • With a decent Gross Margin value of 64.27%, CODX is doing good in the industry, outperforming 68.98% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CODX has declined.
  • The Profit Margin and Operating Margin are not available for CODX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.53%
GM growth 5Y-3.73%
CODX Yearly Profit, Operating, Gross MarginsCODX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20K -40K -60K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CODX Health Analysis

2.1 Basic Checks

  • CODX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CODX has more shares outstanding
  • The number of shares outstanding for CODX has been increased compared to 5 years ago.
  • CODX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CODX Yearly Shares OutstandingCODX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M
CODX Yearly Total Debt VS Total AssetsCODX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -7.30, we must say that CODX is in the distress zone and has some risk of bankruptcy.
  • CODX has a Altman-Z score of -7.30. This is in the lower half of the industry: CODX underperforms 77.01% of its industry peers.
  • CODX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.3
ROIC/WACCN/A
WACC8.94%
CODX Yearly LT Debt VS Equity VS FCFCODX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 3.87 indicates that CODX has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.87, CODX is in the better half of the industry, outperforming 62.03% of the companies in the same industry.
  • A Quick Ratio of 3.59 indicates that CODX has no problem at all paying its short term obligations.
  • CODX's Quick ratio of 3.59 is fine compared to the rest of the industry. CODX outperforms 67.38% of its industry peers.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 3.59
CODX Yearly Current Assets VS Current LiabilitesCODX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CODX Growth Analysis

3.1 Past

  • CODX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.51%, which is quite impressive.
  • Looking at the last year, CODX shows a very negative growth in Revenue. The Revenue has decreased by -84.10% in the last year.
  • Measured over the past years, CODX shows a very negative growth in Revenue. The Revenue has been decreasing by -61.60% on average per year.
EPS 1Y (TTM)33.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.3%
Revenue 1Y (TTM)-84.1%
Revenue growth 3Y-73.7%
Revenue growth 5Y-61.6%
Sales Q2Q%77.18%

3.2 Future

  • Based on estimates for the next years, CODX will show a very strong growth in Earnings Per Share. The EPS will grow by 23.58% on average per year.
  • CODX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 237.24% yearly.
EPS Next Y45.02%
EPS Next 2Y20.7%
EPS Next 3Y19.06%
EPS Next 5Y23.58%
Revenue Next Year18.89%
Revenue Next 2Y495.59%
Revenue Next 3Y396.68%
Revenue Next 5Y237.24%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CODX Yearly Revenue VS EstimatesCODX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
CODX Yearly EPS VS EstimatesCODX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 20 -20 40

More info and screens

Find the best growth stocksShow best growing peers

0

4. CODX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CODX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CODX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CODX Price Earnings VS Forward Price EarningsCODX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CODX Per share dataCODX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15 -20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CODX's earnings are expected to grow with 19.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.7%
EPS Next 3Y19.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CODX Dividend Analysis

5.1 Amount

  • No dividends for CODX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CODX Fundamentals: All Metrics, Ratios and Statistics

CO-DIAGNOSTICS INC

NASDAQ:CODX (4/24/2026, 1:06:35 PM)

1.69

-0.02 (-1.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-31
Earnings (Next)05-06
Inst Owners6.91%
Inst Owner Change0%
Ins Owners3.31%
Ins Owner Change5.92%
Market Cap6.08M
Revenue(TTM)622.50K
Net Income(TTM)-46.90M
Analysts45.71
Price Target30.6 (1710.65%)
Short Float %4.85%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.42%
Min EPS beat(2)0.87%
Max EPS beat(2)1.96%
EPS beat(4)4
Avg EPS beat(4)23.79%
Min EPS beat(4)0.87%
Max EPS beat(4)63.63%
EPS beat(8)6
Avg EPS beat(8)13.9%
EPS beat(12)8
Avg EPS beat(12)-1.27%
EPS beat(16)10
Avg EPS beat(16)-27.55%
Revenue beat(2)1
Avg Revenue beat(2)50.09%
Min Revenue beat(2)-5.23%
Max Revenue beat(2)105.42%
Revenue beat(4)2
Avg Revenue beat(4)4.97%
Min Revenue beat(4)-86.85%
Max Revenue beat(4)105.42%
Revenue beat(8)4
Avg Revenue beat(8)67.01%
Revenue beat(12)5
Avg Revenue beat(12)127.42%
Revenue beat(16)6
Avg Revenue beat(16)84.11%
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.77
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.45
EV/EBITDA N/A
EPS(TTM)-22.54
EYN/A
EPS(NY)-12.39
Fwd EYN/A
FCF(TTM)-8.29
FCFYN/A
OCF(TTM)-8.09
OCFYN/A
SpS0.17
BVpS5.73
TBVpS3.72
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -189.54%
ROE -227.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.27%
FCFM N/A
ROA(3y)-95.27%
ROA(5y)-54.89%
ROE(3y)-112.76%
ROE(5y)-64.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.53%
GM growth 5Y-3.73%
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 63.25%
Cap/Sales 112.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.87
Quick Ratio 3.59
Altman-Z -7.3
F-Score2
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)76.18%
Cap/Depr(5y)107.46%
Cap/Sales(3y)50.54%
Cap/Sales(5y)31.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.3%
EPS Next Y45.02%
EPS Next 2Y20.7%
EPS Next 3Y19.06%
EPS Next 5Y23.58%
Revenue 1Y (TTM)-84.1%
Revenue growth 3Y-73.7%
Revenue growth 5Y-61.6%
Sales Q2Q%77.18%
Revenue Next Year18.89%
Revenue Next 2Y495.59%
Revenue Next 3Y396.68%
Revenue Next 5Y237.24%
EBIT growth 1Y21.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.06%
OCF growth 3YN/A
OCF growth 5YN/A

CO-DIAGNOSTICS INC / CODX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CO-DIAGNOSTICS INC (CODX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CODX.


What is the valuation status of CO-DIAGNOSTICS INC (CODX) stock?

ChartMill assigns a valuation rating of 0 / 10 to CO-DIAGNOSTICS INC (CODX). This can be considered as Overvalued.


Can you provide the profitability details for CO-DIAGNOSTICS INC?

CO-DIAGNOSTICS INC (CODX) has a profitability rating of 1 / 10.


What is the financial health of CO-DIAGNOSTICS INC (CODX) stock?

The financial health rating of CO-DIAGNOSTICS INC (CODX) is 6 / 10.